Crown Electrokinetics (CRKN)
(Real Time Quote from BATS)
$1.22 USD
+0.03 (2.52%)
Updated Sep 23, 2024 11:20 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Crown Electrokinetics Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 1 | 0 | 0 | 0 | 1 |
Gross Profit | -1 | 0 | 0 | 0 | -1 |
Selling & Adminstrative & Depr. & Amort Expenses | 19 | 15 | 0 | 19 | 7 |
Income After Depreciation & Amortization | -19 | -15 | 0 | -19 | -8 |
Non-Operating Income | 0 | 1 | 0 | -18 | 0 |
Interest Expense | 9 | 0 | 0 | 3 | 2 |
Pretax Income | -29 | -14 | 0 | -41 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -29 | -14 | 0 | -41 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -29 | -14 | 0 | -41 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -14 | 0 | -17 | -7 |
Depreciation & Amortization (Cash Flow) | 11 | 1 | 0 | 3 | 1 |
Income After Depreciation & Amortization | -19 | -15 | 0 | -19 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.04 | 0.02 | NA | 0.01 | NA |
Diluted EPS Before Non-Recurring Items | -619.40 | -734.18 | -1,208.71 | -2,614.40 | NA |
Diluted Net EPS (GAAP) | -814.93 | -734.18 | -2,712.89 | -4,118.58 | -698.37 |
Fiscal Year end for Crown Electrokinetics Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 4.65 | 0.68 | 0.09 | 0.00 | 0.04 |
Cost Of Goods | 4.04 | 1.64 | 0.83 | 0.00 | 0.02 |
Gross Profit | 0.61 | -0.95 | -0.74 | 0.00 | 0.01 |
SG&A, R&D, and Dept/Amort Expenses | 5.52 | 2.75 | 6.13 | 3.43 | 4.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | -4.91 | -3.70 | -6.87 | -3.43 | -4.89 |
Non-Operating Income | 0.02 | -0.05 | 0.00 | 3.02 | -7.13 |
Interest Expense | 0.15 | 0.86 | 2.45 | 2.45 | 2.51 |
Pretax Income | -5.03 | -4.61 | -9.31 | -2.86 | -14.52 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -5.03 | -4.61 | -9.31 | -2.86 | -14.52 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -5.03 | -4.61 | -9.31 | -2.86 | -14.52 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1.74 | 0.25 | NA | 0.02 | 0.01 |
Diluted EPS Before Non-Recurring Items | -5.89 | -19.40 | NA | -140.30 | -1,383.58 |
Diluted Net EPS (GAAP) | -5.89 | -19.40 | 2,086.55 | -140.30 | -2,689.55 |